Paper28237397
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma.
Merino-Azpitarte M and 24 others. J Hepatol, 2017. Cited by 92 papers, by iCite.
Cite this record
ConductScience Library. SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma. Papers, record 28237397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28237397
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bile Duct Neoplasms | Major topic |
| Bile Ducts | Major topic |
| Cholangiocarcinoma | Major topic |
| SOXF Transcription Factors | Major topic |
| Tumor Suppressor Proteins | Major topic |
| Animals | |
| Cell Differentiation | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Mice |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K08 DK100575 | NIDDK NIH HHS | United States | K08DK100575 | PubMed and NIH | NIH RePORTER |
| R01 CA183764 | NCI NIH HHS | United States | R01CA183764 | PubMed and NIH | NIH RePORTER |
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23370327 | HDAC6 inhibition restores ciliary expression and decreases tumor growth. | Cancer Res | 2013 | https://conductscience.org/library/papers/23370327 | PubMed |
| 2 | 22136171 | Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages. | J Anat | 2012 | https://conductscience.org/library/papers/22136171 | PubMed |
| 3 | 25689248 | WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited. | J Clin Invest | 2015 | https://conductscience.org/library/papers/25689248 | PubMed |
| 4 | 25706257 | Primary Cilia in Tumor Biology: The Primary Cilium as a Therapeutic Target in Cholangiocarcinoma. | Curr Drug Targets | 2017 | https://conductscience.org/library/papers/25706257 | PubMed |
| 5 | 19549530 | Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis. | Gastroenterology | 2009 | https://conductscience.org/library/papers/19549530 | PubMed |
| 6 | 27095655 | Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). | Nat Rev Gastroenterol Hepatol | 2016 | https://conductscience.org/library/papers/27095655 | PubMed |
| 7 | 24549785 | Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells. | Tumour Biol | 2014 | https://conductscience.org/library/papers/24549785 | PubMed |
| 8 | 24407731 | Low SOX17 expression is a prognostic factor and drives transcriptional dysregulation and esophageal cancer progression. | Int J Cancer | 2014 | https://conductscience.org/library/papers/24407731 | PubMed |
| 9 | 24086078 | Sox proteins: regulators of cell fate specification and differentiation. | Development | 2013 | https://conductscience.org/library/papers/24086078 | PubMed |
| 10 | 25868860 | The SOX17/miR-371-5p/SOX2 axis inhibits EMT, stem cell properties and metastasis in colorectal cancer. | Oncotarget | 2015 | https://conductscience.org/library/papers/25868860 | PubMed |
| 11 | 24665411 | Bile duct epithelial tight junctions and barrier function. | Tissue Barriers | 2013 | https://conductscience.org/library/papers/24665411 | PubMed |
| 12 | 26310932 | Retinoid X receptor α enhances human cholangiocarcinoma growth through simultaneous activation of Wnt/β-catenin and nuclear factor-κB pathways. | Cancer Sci | 2015 | https://conductscience.org/library/papers/26310932 | PubMed |
| 13 | 19619492 | Sox17 regulates organ lineage segregation of ventral foregut progenitor cells. | Dev Cell | 2009 | https://conductscience.org/library/papers/19619492 | PubMed |
| 14 | 22301700 | Cholangiocyte cilia are abnormal in syndromic and non-syndromic biliary atresia. | Mod Pathol | 2012 | https://conductscience.org/library/papers/22301700 | PubMed |
| 15 | 26044126 | Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease. | J Hepatol | 2015 | https://conductscience.org/library/papers/26044126 | PubMed |
| 16 | 22383162 | Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis. | Hepatology | 2012 | https://conductscience.org/library/papers/22383162 | PubMed |
| 17 | 23293295 | Sox17 haploinsufficiency results in perinatal biliary atresia and hepatitis in C57BL/6 background mice. | Development | 2013 | https://conductscience.org/library/papers/23293295 | PubMed |
| 18 | 24501426 | Nek2 phosphorylates and stabilizes β-catenin at mitotic centrosomes downstream of Plk1. | Mol Biol Cell | 2014 | https://conductscience.org/library/papers/24501426 | PubMed |
| 19 | 24520204 | Decitabine in the treatment of acute myeloid leukemia in elderly patients. | Cancer Manag Res | 2014 | https://conductscience.org/library/papers/24520204 | PubMed |
| 20 | 23279592 | Incidentally detected cholangiocarcinoma in an explanted liver with biliary atresia after Kasai operation. | Pediatr Transplant | 2013 | https://conductscience.org/library/papers/23279592 | PubMed |
Cited by56
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 92 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42552468 | Secreted chimeric proteins as a strategy to correct SOX17 deficiency and attenuate the malignant phenotype of cholangiocarcinoma cells: a proof-of-concept study. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42552468 | PubMed |
| 42442510 | Molecular Subtypes of Cholangiocarcinoma and Their Translational Implications. | Gastroenterology | 2026 | https://conductscience.org/library/papers/42442510 | PubMed |
| 42326014 | Transcriptomic profiling of epigenetic regulators and metabolic reprogramming in human cholangiocarcinoma. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42326014 | PubMed |
| 41372578 | Cholangiocarcinoma 2026: status quo, unmet needs and priorities. | Nat Rev Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/41372578 | PubMed |
| 40980689 | Molecular mechanisms and genetic features of cholangiocarcinoma: implications for targeted therapeutic strategies. | Precis Clin Med | 2025 | https://conductscience.org/library/papers/40980689 | PubMed |
| 40355770 | Overexpression of KMT9α is associated with poor outcome in cholangiocarcinoma patients. | J Cancer Res Clin Oncol | 2025 | https://conductscience.org/library/papers/40355770 | PubMed |
| 39878507 | Multi-omics analysis reveals distinct gene regulatory mechanisms between primary and organoid-derived human hepatocytes. | Dis Model Mech | 2025 | https://conductscience.org/library/papers/39878507 | PubMed |
| 39745200 | Positive autoregulation of Sox17 is necessary for gallbladder and extrahepatic bile duct formation. | Development | 2025 | https://conductscience.org/library/papers/39745200 | PubMed |
| 39532242 | Genetic, Epigenetic, and Microenvironmental Drivers of Cholangiocarcinoma. | Am J Pathol | 2025 | https://conductscience.org/library/papers/39532242 | PubMed |
| 39444940 | Recent research progresses of bioengineered biliary stents. | Mater Today Bio | 2024 | https://conductscience.org/library/papers/39444940 | PubMed |
| 39260380 | Wnt/β-Catenin Signaling in Liver Pathobiology. | Annu Rev Pathol | 2025 | https://conductscience.org/library/papers/39260380 | PubMed |
| 39199659 | Unveil Intrahepatic Cholangiocarcinoma Heterogeneity through the Lens of Omics and Multi-Omics Approaches. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39199659 | PubMed |
| 39135601 | Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications. | Med Rev (2021) | 2024 | https://conductscience.org/library/papers/39135601 | PubMed |
| 37737027 | E2F1 Mediates SOX17 Deficiency-Induced Pulmonary Hypertension. | Hypertension | 2023 | https://conductscience.org/library/papers/37737027 | PubMed |
| 37643784 | Pan-cancer Analysis Reveals Cancer-dependent Expression of SOX17 and Associated Clinical Outcomes. | Cancer Genomics Proteomics | 2023 | https://conductscience.org/library/papers/37643784 | PubMed |
| 37576970 | The dynamic expression of SOX17 in germ cells from human female foetus and adult ovaries after specification. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37576970 | PubMed |
| 37197436 | An overview of extrahepatic cholangiocarcinoma: from here to where? | Front Oncol | 2023 | https://conductscience.org/library/papers/37197436 | PubMed |
| 37190050 | Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity. | Cells | 2023 | https://conductscience.org/library/papers/37190050 | PubMed |
| 36848245 | MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells. | J Hepatol | 2023 | https://conductscience.org/library/papers/36848245 | PubMed |
| 36755084 | Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance. | Nat Rev Gastroenterol Hepatol | 2023 | https://conductscience.org/library/papers/36755084 | PubMed |
Genes33
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28237397
GET https://conductscience.org/api/papers/v1/28237397/authors?page=2